18:49 , May 23, 2019 |  BC Extra  |  Financial News

May 23 Financial Quick Takes: NYSE to lower fees for biotechs; plus Guardant and more

NYSE proposes lower fees for prerevenue biotechs  For biotech companies with a market cap of at least $200 million and annual revenues of $5 million or less, the New York Stock Exchange proposed in an...
07:00 , Aug 8, 2016 |  BioCentury  |  Product Development

Galvanizing bioelectronics

With disease biology expertise from GlaxoSmithKline plc and device development know-how from Verily Life Sciences LLC, newco Galvani Bioelectronics Ltd. plans to bring a commercial-grade bioelectronic therapeutic device to the clinic in about four years....
08:00 , Feb 22, 2016 |  BC Week In Review  |  Financial News

Cala Health completes venture financing

Cala Health Inc. , Burlingame, Calif.   Business: Neurology   Date completed: 2016-02-16   Type: Venture financing   Raised: $18 million   Note: Cala raised $18 million, according to an SEC filing.  ...